Cargando…
Effects of Adamantyl Derivatives on Pharmacokinetic Behavior of Paclitaxel in Rats
Paclitaxel (PTX) is one of the most frequently used anticancer agent for treating refractory ovarian cancer, metastatic breast cancer and non-small cell lung cancer. However, its oral administration is impeded by very low bioavailability (<5%) due to the Pglycopprotein (P-gp) efflux pump effect....
Autores principales: | Kim, Kyung Mi, Lee, Kyeong, Jang, Kyusic, Moon, Yae Seul, Lee, Hwa Jeong, Rhie, Sandy Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590800/ https://www.ncbi.nlm.nih.gov/pubmed/28173641 http://dx.doi.org/10.4062/biomolther.2016.191 |
Ejemplares similares
-
Effects of Piperazine Derivative on Paclitaxel Pharmacokinetics
por: Lee, Jaeok, et al.
Publicado: (2019) -
Pharmacokinetic Alteration of Paclitaxel by Ferulic Acid Derivative
por: Lee, Jaeok, et al.
Publicado: (2019) -
LC478, a Novel Di-Substituted Adamantyl Derivative, Enhances the Oral Bioavailability of Docetaxel in Rats
por: Han, Seung Yon, et al.
Publicado: (2019) -
Pharmacokinetic Study of NADPH Oxidase Inhibitor Ewha-18278, a Pyrazole Derivative
por: Lee, Seul Gee, et al.
Publicado: (2019) -
Adamantyl and homoadamantyl derivatives from Garcinia multiflora fruits
por: Chen, Yu, et al.
Publicado: (2019)